275
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Radical Radiotherapy of Inoperable non-Small Cell Lung Cancer: Irradiation techniques and tumor characteristics in relation to local control and survival

, &
Pages 555-561 | Received 24 Apr 1991, Accepted 12 Apr 1992, Published online: 08 Jul 2009
 

Abstract

The relation between tumor characteristics, irradiation technique, local tumor control and survival was retrospectively studied in 323 patients with non-small cell lung cancer who started radical radiotherapy in 1974–1981. At that time three non-randomized different fractionation schedules were used: 16 × 3.25 Gy, total dose 52 Gy, 3 fractions/week (schedule l), 11 × 4 Gy, total dose 44 Gy, 2 fractions/week (schedule 2) and 25 × 2 Gy, total dose 50 Gy, 5 fractions/week (schedule 3). The highest survival rates were observed in the patient group treated according to schedule 2. The 2-year survival rate was 30% compared with 18% and 6% in the patients treated according to schedule 1 and 3 respectively. However, this can at least partly be explained by patient selection. A correlation between size of the tumor, target volume and survival was observed: the larger the tumor, the poorer the survival. Pleural effusion showed to be an unfavorable prognostic factor. The prognosis of inoperable lung cancer on the whole remained poor: the 1-year survival rate was 43% and 2-year survival rate 16%. Only 3% of the patients lived at least five years.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.